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OBJECTIVE: The present study aimed to evaluate the sedative and anxiolytic effects of the essential oils and
hydroalcoholic extract of Kelussia odoratissima Mozaff. (K. odoratissima) in mice by utilizing an elevated plus maze.
The chemical composition of its essential oil was also determined.
METHODS: The hydroalcoholic extract or essential oil fraction from this plant were administered intraperitoneally
to male mice at various doses 30 min before testing. The anxiolytic and sedative effects were determined by an
elevated plus maze and locomotor activity tests, respectively.
RESULTS: According to the results, none of the administered doses of hydroalcoholic extract or essential oil fraction
of K. odoratissima changed the percentage of the time spent or number of entries into the open arms of the
elevated plus maze. In contrast, the cumulative spontaneous locomotor activity of mice treated with the essential oil
or hydroalcoholic extract was significantly decreased. Chemical analysis of the essential oil by Gas chromatography-
mass spectromentry (GC-MS) showed that 3-butylidene-4,5-dihydrophthalide (85.9%) was the major component.
CONCLUSION: These data confirm the sedative properties of K. odoratissima, yet there were no profound anxiolytic
effects observed.
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INTRODUCTION
Anxiety disorders are among the most varied mental
disorders, and they normally have a considerable impact on
quality of life. Substantial and prolonged stress and anxiety
can adversely affect immune function, hormone levels,
enzymes and gastrointestinal function. With a worldwide
occurrence of 16.6%, anxiety disorders are among the most
common mental disorders and a major cause of disability.
1
A wide range of medications are available for the treatment
of stress and anxiety-related conditions; however, none of
these therapies are completely safe and without adverse
effects. Interventions for stress and anxiety range from
nutritional support to the use of medications such
as benzodiazepines, antidepressants, b-blockers and
antipsychotics.
2
In the search for safer therapeutic products, researchers
worldwide have explored traditional remedies to find a
suitable treatment for anxiety-related disorders.
3-7 Among
the tested herbal extracts, kava has been shown to produce
some of the best results in relieving anxiety symptoms,
2
although its association with hepatotoxicity is of a sig-
nificant concern. Recently, a United States Patent
(No. 6,582,735) was granted for the use of an extract from
Magnolia officinalis bark for stress-related conditions invol-
ving elevated cortisol, which may include patients present-
ing with poor control of body weight, sleep disturbances
and restlessness. In Iran, a favorable climate and geography
have contributed to a diversity of medicinal plants, and
many endemic plant species exist. The Umbelliferae family
contains approximately 275 genera and 2,850 species.
8
Kelussia is one of the newest genera of this family and is
represented by only one species, Kelussia odoratissima
Mozaff., which is found only in Iran.
9 This sweet-smelling,
self-growing monotypic medicinal plant is endemic to a
restricted area in western Iran and locally called ‘‘Karafs-e-
koohi’’. The aerial part of the plant is commonly used as a
popular garnish and a sedative medicinal plant. Currently,
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843there are limited studies examining the pharmacological
properties of this plant. Except for a recent publication on
the antioxidant activity of K. odoratissima,
10 there have been
no other published reports regarding the pharmacology of
this plant.
As a continuation of our previous studies on sedative
medicinal plants growing wild in Iran, this study aimed to
examine the anxiolytic and sedative effects of K. odoratis-
sima. The major constituents of the essential oils derived
from this plant were also investigated by gas chromato-
graphy-mass spectroscopy. To our knowledge, we are the
first group to report the chemical composition of the
essential oils derived from the aerial parts of K. odoratissima.
MATERIALS AND METHODS
Preparation of the plant materials
The aerial parts of K. odoratissima were collected from the
central Zagros region of western Iran in March 2006. The
plant was identified at the Botany Department of Isfahan
University, and a voucher specimen (No. 2022) was
deposited at the Herbarium of the Faculty of Pharmacy
and Pharmaceutical Sciences, Isfahan University of Medical
Sciences, Isfahan, Iran.
Hydroalcoholic extract: The air-dried aerial parts of K.
odoratissima were extracted by maceration at room tempera-
ture with ethanol:water (8:2). The extract was concentrated
in a rotary evaporator Bibby RE200, UK under reduced
pressure to produce a viscous residue. The yield of the
extract was 44.4% (w/w). An appropriate amount of the
extract was diluted with distilled water (containing 0.5% of
Tween 80) to produce the final stock solution.
Isolation of essential oil: The air-dried aerial parts of K.
odoratissima were reduced to a course powder, and the oils
were isolated by hydrodistillation using a Clevenger-type
apparatus for 3 h according to the method recommended in
the British Pharmacopeia.
11 The essential oil was dried over
anhydrous sodium sulfate and stored in a sealed vial at 4 ˚C
until analysis. The yield of the oil was calculated based on
the dried weight of the plant material. An appropriate
amount of essential oil was diluted with distilled water
(containing 2 drops of Tween 80 per 10 ml) to produce the
final working concentration for pharmacological tests.
Gas chromatography-mass spectroscopy analysis
Gas chromatography combined with mass spectrometry
was used for identification of the components of the
essential oil. The analysis was performed on a Hewlett-
Packard 6890 gas chromatograph fitted with a fused silica
HP-5MS capillary column (30 m 6 0.25 mm; coating
thickness of 0.25 mm). The oven temperature was pro-
grammed to increase from 60 to 280 ˚C at a rate of 4 ˚C/min.
Helium was used as carrier gas at a flow rate of 2 ml/min.
The gas was coupled to a Hewlett-Packard 5972A Mass
Selective Detector. The MS operating parameters were the
following: ionization voltage of 70 eV and ion source
temperature of 200 ˚C.
Identification of components
Identification of the components of the essential oil was
based on GC retention indices relative to n-alkanes and
computer matching with the Wiley 275 L mass spectra
library. In addition, the analysis included comparisons of
the fragmentation patterns of the mass spectra to those
reported in the literature.
12,13
Animals
All pharmacological experiments were performed on
male NMRI mice (25 to 30 g) that were obtained from the
Pasteur Institute (Tehran, Iran). The animals were housed in
groups of six in cages at 22 to 25 ˚C under a 12-h light/dark
cycle (lights on at 07:00 h) with free access to food and
water. To reduce the influence of diurnal variations, all
experiments were conducted from 08:00 to 13:00 h in a
special noise-free room with controlled illumination. The
experiments were performed in a separate room from where
the animals had been habituated. A minimum of six mice
were used for each treatment group. The animals were
housed and used in accordance with the guidelines of the
committee on care and use of laboratory animal resources of
the Isfahan University of Medical Sciences.
Drug preparations
Diazepam hydrochloride was purchased from Chemi
Darou (Tehran, Iran) in 10 mg/2 ml ampoules and diluted
to an appropriate concentration using normal saline
containing 0.5% Tween 80. Different concentrations of the
plant extract and essential oil were prepared using normal
saline and 0.5% Tween 80. All solutions were prepared fresh
on test days and administered i.p. in a volume of 0.1 ml/10 g
body weight of mice.
Elevated plus maze
Anxiolytic activity was measured using the elevated plus
maze (EPM) test. The maze consisted of two open (30 cm 6
5c m60.2 cm) and two closed (30 cm65c m615 cm) arms
that extended from a central platform (5 cm 6 5 cm) and
was elevated to a height of 45 cm above the floor.
14 The
entire maze was wooden and painted black.
Mice were administered a single i.p. dose of diazepam,
vehicle, extract or essential oil 30 min before their placement
on the EPM. At the start of the session, the mouse was placed
at the center of the maze facing an open arm, and the number
of entries and the time spent in each of the closed and open
arms were recorded during a 5-min observation period. Arm
entries were defined as the entry of all four paws into the
arm. The percentage of open arm entries (100 6open/total
entries) and open arm time (100 6 open/open+closed arm
time) was calculated for each animal. Between each trial, the
maze was wiped clean with a damp sponge and dried with
paper towels.
Locomotor activity
To monitor spontaneous locomotor activity, the distance
traversed by a mouse in its home cage (measuring 406406
20 cm) was monitored via a computerized infrared tracking
device (School of Pharmacy, Isfahan). The units for the
activity counts were based on the number of beam breaks
triggered by the movement of the mouse. Each mouse was
injected with a single dose of diazepam, vehicle, extract or
essential oil 30 min prior to the test and then placed in a
novel cage in the infrared apparatus. The locomotor activity
was measured at 5-min intervals for a total of 15 min. Six
mice were used for each treatment group. The treatments
were randomized throughout the day (between 08:00 and
13:00 h) to control for diurnal variations in activity.
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All data are expressed as mean ¡ SEM. The differences
among multiple groups were first analyzed by ANOVA.
When a statistically significant difference was detected,
Dunnett’s t-test was used to determine statistical signifi-
cance among multiple test groups and the corresponding
control. A Student’s t test was used to evaluate the statistical
significance between two groups. These statistical compar-
isons were analyzed using SigmaStat software (San Jose,
CA). Statistical significance was established at 95%.
RESULTS
GC-MS analysis
The aerial parts of K. odoratissima yielded a 0.4% yellowish
essential oil. The identified components and their percen-
tages are given in Table 1, and the components are listed in
order of their elution from the HP-5MS column.
Elevated plus maze
In the elevated plus-maze, 1.5 mg/kg diazepam signifi-
cantly increased the percentage of time spent and number of
entries into the open arms (p , 0.05; Figs. 1 A and B). Based
on pilot studies, three doses (50, 100 and 200 mg/kg) of the
hydroalcoholic extract (HE) and essential oil were evaluated
for anxiolytic activities. As shown in Figs. 1 A and B, none of
the administered doses of HE or essential oil from K.
odoratissima significantly changed the percentage of time
spent or number of entries into the open arms.
Spontaneous locomotor activity test
The spontaneous locomotor activity was measured at 5-min
intervals for 15 min. As shown in Figs. 2 A and B, locomotor
activity was significantly decreased in animals injected with
diazepam at all three intervals (5, 10 and 15 min), and there was
a decrease in the cumulative locomotor activity over the total 15-
min test time (p , 0 . 0 5 ;F i g s .2A ,B ) .T h ee f f e c t so fH Ea n dt h e
essential oil fraction from K. odoratissima on locomotor activity
were tested at 50 mg/kg. The HE at 50 mg/kg significantly
decreased both locomotor activity in the first and second
intervals (5 and 10 min) and the cumulative locomotor activity (p
,0.05; Figs. 2 A, B). Although the essential oil fraction decreased
the locomotor activity in all three intervals, this decrease was not
statistically significant. However, there was a significant
decrease in the cumulative locomotor activity after administra-
tion of the essential oil of the plant (p , 0.05; Figs. 2 A, B).
DISCUSSION
The aims of the present study were (1) to evaluate the
sedative and anxiolytic effects of the HE and essential oils
from K. odoratissima and (2) to determine the main
constituents of the essential oil fraction. To assess the
anxiolytic effects of this Iranian plant, an EPM was used to
assess anxiety. In agreement with previously published
reports, diazepam increased the percentage of time spent
and number of entries into the open arms,
15-17 which
confirmed the validity of the EPM model and the anxiolytic
activity of diazepam.
18 In contrast to diazepam, the total HE
and essential oils from K. odoratissima did not produce
significant increases in the EPM parameters, thereby
indicating a lack of anxiolytic-like effects. Several explana-
tions can be given for this lack of an anxiolytic effect. First, it
is possible that the plant does not contain any bioactive,
detectable constituent to produce anxiolytic effects.
Therefore, the calming effect of the plant reported after
consuming the dried aerial parts could be due to reduced
locomotor activity, which we witnessed in this study.
The other possible reason for not observing the anxiolytic
effects of this plant was the experimental model of anxiety. EPM
is currently one of the most widely used models of animal
anxiety and has been validated in both rats and mice.
19 This test
is based on the natural conflict between the drive to explore a
new environment and the tendency to avoid a potentially
dangerous area. Thus, all behaviors measured in the EPM
depend, directly or indirectly, on motor activity, which is
probably the main confounding factor in these so-called
ethological tests. The approach-avoidance conflict can be
resolved by anxiolytic drugs such as benzodiazepines, which
produce an increase in the approach levels without necessarily
affecting locomotion in the protected areas.
20,21 The EPM model
of anxiety has several practical limitations that could also make
data interpretation difficult; however, these problems could
perhaps be resolved by the addition of a conditional anxiety
model.
20,22-25
Both the total HE and the essential oil fraction from K.
odoratissima significantly decreased the spontaneous locomotor
activity of mice. This reduction in locomotor activity could
either be due to the plant’s acti o no nt h eC N So rad i r e c te f f e c t
on the periphery. In any case, this effect of K. odoratissima is
consistent with its folk use as a tranquilizing agent. Further
studies are required to determine the mechanism for the
sedative action of this plant. K. odoratissima has been shown to
possess several medicinal properties, which include its activities
Table 1 - Percentage composition of the essential oil from
K. odoratissima leaf analyzed by GC-MS.
No. Compound % RI
1 n-propyl benzene 0.2 953
2 Limonene t 1028
3 A-terpinolene 0.1 1085
4 Unknown 1.7 1157
5 Unknown 6.2 1282
6 2-undecanone 0.1 1291
7 4-vinyl-2-methoxy phenol 0.2 1312
8 A-cubebene 0.1 1347
9 neryl acetate t 1363
10 A-copaene 1.4 1372
11 B- cubebene t 1386
12 B-elemene t 1387
13 B-caryophyllene 0.3 1414
14 A-humulene 0.2 1450
15 trans-b-farnesene 0.1 1453
16 B-acoradiene 0.1 1461
17 germacrene-D 0.3 1475
18 b-himachalene 0.3 1494
19 Cuparene 0.1 1498
20 germacrene-A 0.2 1503
21 b-curcumene 0.3 1511
22 d-cadinene 0.7 1522
23 cadina 1,4-diene 0.1 1525
24 cis-3-butylidene phthalide 0.4 1667
25 3-butylidene-4,5-dihydrophthalide 85.9 1735
27 3N butyl phthalide 0.3 1815
ligustilide: 3-butylidene-4,5-dihydrophthalide.
Retention indices on a HP-5MS capillary column.
t: trace (# 0.05%).
%: Calculated from TIC data.
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also prevents fatty streak formation. However, no one so far has
examined the CNS calming effects of the plant.
26
The essential oil of K. odoratissima consists of 27
components, which represent 99.3% of the total essential
oils. The main constituents of the essential oil are phtha-
lides, which include 3-butylidene-4,5-dihydrophthalide (z-
Ligustilide) (85.9%), cis-3butylidene phthalide (0.4%) and
3N butyl phthalide (0.3%). The other main identified
components of the essential oil of K. odoratissima are a-
copaene (1.4%) and d-cadinene (0.7%).
Phthalides, and their corresponding dihydro and tetra-
hydro analogs, are components of several genera from the
plant family Apiaceae.
27 They are bioactive phytochemicals
and have important molecular and cellular effects, which
include the inhibition of DNMTs (DNA methyltransferases)
by targeting DNA hypermethylation,
28 stimulation of
glutathione transferase activity,
29 antiproliferative effects
on colon cancer cells,
30 potential anti-fibrotic effects for the
treatment and prevention of hepatic fibrosis
31 and protec-
tive effects on focal cerebral ischemia in rats.
32 Numerous
studies have examined the effects of the phthalide family
Figure 1 - The effects of diazepam, vehicle and different doses of K. odoratissima essential oil and extract on (A) the percentage of time
mice spent in the open arms and on (B) the percentage of entries into the open arms during a 5-min test. Various doses of the plant’s
essential oil or extract, diazepam or vehicle were injected 30 min prior to testing. Data are presented as mean values ¡ SEM for each
group of 6 mice. *p , 0.05 compared to control group.
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LIG). This compound has diverse biological activities, which
include smooth muscle relaxation, improved microcircula-
tion, antiasthmatic and analgesic effects, antiproliferative
effects on smooth muscle cells and significant neuroprotec-
tive effects against transient forebrain ischemia in mice and
focal cerebral ischemia in rats through antioxidant and
antiapoptotic mechanisms.
33
In conclusion, the results of the present study provide
evidence for the sedative property of K. odoratissima, which
may be mediated by the bioactive phtalides
34 contained in
this plant. Further studies are underway to examine the
Figure 2 - The effects of diazepam, vehicle, and different doses of K. odoratissima essential oil and extract on (A) spontaneous
locomotor activity during three 5-min intervals and on (B) spontaneous locomotor activity during the total 15 min of testing. The
locomotor activity counts (mean ¡ SEM) were measured over a 15-min period beginning 30 min after the administration of vehicle,
diazepam, plant essential oil or extract. Data are presented as mean ¡ SEM for each group of 6 mice. *p , 0.05 compared to control
group.
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847other constituents of this plant and their therapeutic
potential.
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